Catalyst

$BMY

- Biopharmaceutical company developing medicines for serious diseases.

BMY

$57.52

+3.85%

What changed

$BMY - Biopharmaceutical company developing medicines for serious diseases. - REV +3% to $11.5B - EPS +?% to $1.58

Why it matters

FDA approval for lung cancer drug Opdivo expands $BMY addressable market by 30%.

Sources

pipeline